Ainos (AIMD) had the highest return between October 1, 2016 and October 30, 2016 by a US stock, returning 3,746.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Ainos (AIMD) | 10/1/2016 - 10/30/2016 | 3,746.15% |
Arena (AREN) | 10/1/2016 - 10/30/2016 | 347.5% |
SurgePays (SURG) | 10/1/2016 - 10/30/2016 | 223.08% |
Intrusion (INTZ) | 10/1/2016 - 10/30/2016 | 212.3% |
Lexaria Bioscience (LEXX) | 10/1/2016 - 10/30/2016 | 117.74% |
Greenwave Technology Solutions Inc Common Stock (GWAV) | 10/1/2016 - 10/30/2016 | 105.12% |
Assembly Biosciences (ASMB) | 10/1/2016 - 10/30/2016 | 91.72% |
Gravity (GRVY) | 10/1/2016 - 10/30/2016 | 88.82% |
374Water Inc Common Stock (SCWO) | 10/1/2016 - 10/30/2016 | 87.5% |
Hepion Pharmaceuticals (HEPA) | 10/1/2016 - 10/30/2016 | 78.7% |
Zivo Bioscience (ZIVO) | 10/1/2016 - 10/30/2016 | 76.47% |
Anixa Biosciences (ANIX) | 10/1/2016 - 10/30/2016 | 68.75% |
Alpha Metallurgical Resources (AMR) | 10/1/2016 - 10/30/2016 | 64.29% |
Nutex Health (NUTX) | 10/1/2016 - 10/30/2016 | 63.17% |
Aurora Cannabis (ACB) | 10/1/2016 - 10/30/2016 | 59.43% |
Canopy Growth (CGC) | 10/1/2016 - 10/30/2016 | 51.73% |
Sunshine Biopharma (SBFM) | 10/1/2016 - 10/30/2016 | 49.71% |
Zynex (ZYXI) | 10/1/2016 - 10/30/2016 | 49.69% |
OrganiGram (OGI) | 10/1/2016 - 10/30/2016 | 48.34% |
CEA Industries (CEAD) | 10/1/2016 - 10/30/2016 | 48.24% |
Qualigen Therapeutics (QLGN) | 10/1/2016 - 10/30/2016 | 46.47% |
InMed Pharmaceuticals (INM) | 10/1/2016 - 10/30/2016 | 46.1% |
Aemetis (AMTX) | 10/1/2016 - 10/30/2016 | 46.02% |
Koss (KOSS) | 10/1/2016 - 10/30/2016 | 45.84% |
VOXX International (VOXX) | 10/1/2016 - 10/30/2016 | 45% |
